CRIS
Curis IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$23.25M
P/E Ratio
—
EPS
$-0.58
Beta
3.14
52W High
$3.13
52W Low
$0.49
50-Day MA
$0.80
200-Day MA
$1.25
Dividend Yield
—
Profit Margin
-80.30%
Forward P/E
—
PEG Ratio
0.00
About Curis Inc
Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States. The company is headquartered in Lexington, Massachusetts.
Fundamentals
| Revenue (TTM) | $9.44M |
| Gross Profit (TTM) | $-18.86M |
| EBITDA | $-32.73M |
| Operating Margin | -665.00% |
| Return on Equity | -2951.00% |
| Return on Assets | -67.20% |
| Revenue/Share (TTM) | $0.72 |
| Book Value | $0.42 |
| Price-to-Book | 4.39 |
| Price-to-Sales (TTM) | 2.46 |
| EV/Revenue | 2.172 |
| EV/EBITDA | 0.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -66.00% |
| Shares Outstanding | $39.98M |
| Float | $33.11M |
| % Insiders | 2.95% |
| % Institutions | 25.08% |
Historical Volatility
HV 10-Day
95.93%
HV 20-Day
110.43%
HV 30-Day
114.26%
HV 60-Day
99.46%
HV Rank
90.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.00 target)
1
Strong Buy3
BuyData last updated: 4/28/2026